Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy.

Eur J Haematol

Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Scientific Directorate, G. Gaslini Children's Hospital, Genova, Italy.

Published: January 2005

The aim of this retrospective study was to test the residual humoral immunity to compulsory vaccines after the end of chemotherapy for acute lymphoblastic leukaemia in a cohort of 70 Italian children. All the patients, who had been immunised according to the Italian schedule prior to the disease, were tested for antibody levels against tetanus and hepatitis B at a median of 10 months after the end of therapy. Median age at diagnosis of leukaemia was 48 months, and median age at vaccine titration was 84 months. The protective level of antibodies for tetanus and hepatitis B was shown in 83% and 81% of patients, respectively; the remaining 17% and 19% were not protected against the two pathogens. Double negativity was observed in only four of 62 (6%) patients in the cohort. These data were comparable with published data regarding healthy children of the same age and from the same geographical areas. Therefore, given the direct and indirect costs of performing laboratory tests, as well as the cost of revaccination, our proposal is to continue the vaccination schedule according to the child's age without any titration screening 6 months after the end of therapy. Larger studies are needed to confirm these observations.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2004.00340.xDOI Listing

Publication Analysis

Top Keywords

tetanus hepatitis
8
months therapy
8
median age
8
re-immunisation schedule
4
schedule leukaemic
4
leukaemic children
4
children intensive
4
intensive chemotherapy
4
chemotherapy strategy
4
strategy aim
4

Similar Publications

: The development of a five-in-one vaccine microneedle patch (five-in-one MN patch) aims to address challenges in administering vaccines against Diphtheria (DT), Tetanus (TT), Pertussis (wP), Hepatitis B (HBsAg), and type b (Hib). Combining multiple vaccines into a single patch offers a novel solution to improve vaccine accessibility, stability, and delivery efficiency, particularly in resource-limited settings. : The five-in-one MN patch consists of four distinct microneedle arrays: DT and TT vaccines are coated together on one array, while wP, HepB, and Hib vaccines are coated separately on individual arrays.

View Article and Find Full Text PDF

[Microplanning as a tool to strengthen the National Immunization Program in BrazilLa microplanificación como herramienta para fortalecer el Programa Nacional de Inmunizaciones en Brasil].

Rev Panam Salud Publica

December 2024

Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente Departamento de Doenças Imunopreveníveis Brasília (DF) Brasil Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Departamento de Doenças Imunopreveníveis, Brasília (DF), Brasil.

Objective: To measure the variation in number of doses, vaccination coverage (VC) of administered vaccines, and number of municipalities that achieved the VC target in Brazil with the implementation of microplanning for high-quality vaccination activities (HQVA) and decentralized multivaccination actions.

Methods: This quasi-experimental study used data from the National Live Birth Information System, the National Immunization Program Information System, and the National Health Data Network. The number of doses of hepatitis A (HA), meningococcal conjugate-C, oral poliomyelitis, 10-valent pneumococcal, diphtheria-tetanus-pertussis (DTP), and measles-mumps-rubella (MMR) vaccines administered to children under 2 years of age in 2022 (pre-microplanning) and 2023 (post-microplanning) was estimated.

View Article and Find Full Text PDF

Aim: Vaccines have been shown to have the highest efficacy in preventing infectious diseases through their ability to induce immunological memory against pathogens. An adverse reaction to a vaccine is an unexpected medical occurrence following immunization. Complex regional pain syndrome (CRPS) is a disease that has undergone much controversy regarding its onset post-vaccination.

View Article and Find Full Text PDF

Inequalities in uptake of childhood vaccination in England, 2019-23: longitudinal study.

BMJ

December 2024

Department of Public Health, Policy and Systems, Institute of Population Health, University of Liverpool, Liverpool, UK.

Objective: To quantify changes in inequalities in uptake of childhood vaccination during a period of steadily declining overall childhood vaccination rates in England.

Design: Longitudinal study.

Setting: General practice data for five vaccines administered to children (first and second doses of the measles, mumps, and rubella vaccine (MMR1 and MMR2, respectively), rotavirus vaccine, pneumococcal conjugate vaccine (PCV) booster, and six-in-one (DTaP/IPV/Hib/HepB) vaccine covering diphtheria, tetanus, pertussis, polio, type b, and hepatitis B) from the Cover of Vaccination Uptake Evaluated Rapidly dataset in England.

View Article and Find Full Text PDF
Article Synopsis
  • Large-scale public health programs in India, such as immunizations and deworming, currently operate independently, which limits their overall efficiency.
  • An analysis of survey data from over 86,000 children revealed that vaccination coverage varied significantly, with some vaccines reaching as low as 42% and others up to 95%, highlighting areas needing attention.
  • Implementing an integrated strategy that combines multiple health interventions could significantly improve vaccine coverage and efficiency, suggesting that targeting specific under-vaccinated districts could lead to better health outcomes for children in India.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!